Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Medtronic and Abbott make progress on interoperable diabetes tech—is FDA clearance next?
Two of the world's leading medtech companies have been collaborating to improve patient access to CGM technology. It now looks like Medtronic and Abbott could be close to gaining FDA clearance and moving forward to the next phase of their partnership.
AI-powered risk model evaluates long-term risk of coronary artery disease
The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available.
Mediterranean diets that include some lean red meat can still boost cardiovascular health
The study's authors focused on blood pressure reductions and arterial stiffness, sharing their findings in Current Developments in Nutrition.
Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’
Researchers still think patients should receive an injectable version of semaglutide when possible, but new data out of ACC.25 confirm that an oral formulation of the drug is associated with significant benefits.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

Abbott’s newest glucose monitoring device gains FDA clearance

The news comes after Abbott had to recall more than 4.2 million older glucose monitoring systems due to issues with batteries overheating.

Clopidogrel linked to better long-term outcomes than aspirin in PCI patients with and without diabetes

Clopidogrel is especially effective at limiting major adverse cardiovascular events among PCI patients with diabetes, researchers found.

Age more helpful than weight when screening for diabetes

While the U.S. Preventive Services Task Force still uses weight to guide its screening recommendations, new research suggests focusing on age alone provides more value.

FDA announces recall of 4.2M Abbott devices after hundreds of incidents, including multiple fires

Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.

New diet, an updated take on intermittent fasting, may lower risk of type 2 diabetes

This new approach, which combines traditional intermittent fasting with 20-hour fasting periods on nonconsecutive days, could make a big impact on the cardiovascular health of high-risk patients.

Antibiotic recalled due to risk of endocarditis, other life-threatening infections

According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.

Abbott FreeStyle Libre 2 glucose monitor

Abbott warns that device batteries may overheat or catch fire

The company emphasized that the issues are quite rare. No devices are being recalled, and it is not recommended that customers stop using them.

doctor fruits vegetables vegetarian diet

Mediterranean diet comes out on top in new comparison of popular ‘heart-healthy’ diets

Low-fat diets were also linked to certain benefits, including a reduced heart attack risk.

Heart Health

Medtronic and Abbott make progress on interoperable diabetes tech—is FDA clearance next?

AI-powered risk model evaluates long-term risk of coronary artery disease

Mediterranean diets that include some lean red meat can still boost cardiovascular health

Plant-based diets may help patients with diabetes, heart disease live longer

Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’